Analyst Has 3 Biotech Stocks to Buy With Over 100% Upside Potential
The three biotech stocks featured here are rated Outperform at Wedbush and have at least 100% potential upside to the posted price targets.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 196
How Sarepta Is Cashing In on Its FDA Homerun
Making the move for a secondary offering after a stock has jumped massively is one way for companies to literally cash in on their recent success.
Obesity, Violence Helps Push US to No. 28 in Global Health Ratings
The United States does not do very well in a recent study measuring the health-related sustainable development goals in 188 countries, due to decades of growing obesity and ongoing violence.
Eleven Bio Finds Even More Pipeline Growth in M&A
Eleven Biotherapeutics announced that it has entered into a definitive agreement to acquire Viventia and its lead product candidates Vicinium and Proxinium.
Tobira Therapeutics Skyrockets on Allergan Acquisition
Tobira Therapeutics shares skyrocketed on Tuesday after Allergan announced that it will acquire the company.
Puma Biotech Rises on Key FDA Approval
Shares of Puma Biotechnology had a strong gain in Tuesday’s session following some positive news from the FDA on the company's breast cancer treatment.
Sarepta Scores Big on Highly Contested FDA Approval
Sarepta Therapeutics cleared another hurdle related to its Duchenne muscular dystrophy treatment, and the stock practically doubled on Monday.
Community Health May Be Planning Sale
Shares of Community Health Systems retreated on Monday, after making a sizable gain in Friday’s session on news that the company might be pursuing an option to sell.
RBC Says These 4 Top Biotechs Could Have Big Upside Potential
An RBC report noted that although headline issues such as the Federal Reserve and the election are increasing volatility, four top biotech companies may be a solid play now.
Is This the Ultimate Implosion of Novavax?
Novavax was pummeled by shareholders on Friday after the company reported top-line results from its RSV F Vaccine trials.
Has AcelRx Pharmaceuticals Hit a Home Run?
Shares of AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) surged following positive results from a late-stage trial. The company announced the outcome of an open-label Phase 3 trial (SAP303) of investigational product candidate ARX-04. Let us just say, it…
Caladrius Bio Jumps on Private Placement Deal
Caladrius Biosciences watched its shares soar on Thursday after the company announced a private placement offering.
Why Aeri Pharma Won So Big on a Single Trial
Shares of Aeri Pharmaceuticals skyrocketed early Thursday after the company issued positive results on its intraocular pressure (IOP) treatment in patients with glaucoma.
Why This FDA Departure Is Huge for Sarepta
Sarepta Therapeutics closed out Wednesday with its shares up over 25% following positive developments surrounding eteplirsen, its treatment of Duchenne muscular dystrophy.
Acasti Pharma Share Gains Massive in Percentage Terms, Tiny in Dollars
It is not that often that you see biotech or biohealth stocks moving north of 50% in one trading session. If you do it is usually due to merger news or a rumor about…